Times Online  May 18  Comment 
Conservative co-chairman Lord Feldman has denied being responsible for an alleged comment describing grassroots party activists as “mad, swivel-eyed loons”....
Benzinga  Apr 30  Comment 
In a report published Tuesday, Bank of America analyst James Feldman upgraded the rating on Kilroy Realty Corp. (NYSE: KRC) from Neutral to Buy, and raised the price target from $56.00 to $60.00. In the report, Feldman noted, “This morning,...
TechCrunch  Apr 17  Comment 
Online display advertising has been a murky business -- who is actually viewing all those ads, and do those ads make a difference to them? Quantcast has been quietly trying to solve this problem since 2006, and now it's starting to break out. I'm...
Benzinga  Apr 9  Comment 
In a report published Tuesday, Deutsche Bank analyst Brett Feldman initiated coverage on CenturyLink (NYSE: CTL) with a Hold rating and $35.00 price target. In the report, Feldman noted, “We are initiating coverage of CenturyLink (CTL) with a...
New York Times  Feb 18  Comment 
On Monday, the brand will, for the first time, advertise its pregnancy test and ovulation prediction kit to a Spanish-speaking audience on television networks that include Univision, Galavision, Telemundo and MTV Tres.
New York Times  Jan 8  Comment 
Mr. Feldman is the founder and managing partner of the HFZ Capital Group, a real estate development and investment company that he formed in 2005.
TechCrunch  Jan 8  Comment 
Online measurement and ad targeting company Quantcast has acquired MakeGood (also known as MakeGood Software), a Seattle-based ad tech startup founded in 2009. Quantcast CEO Konrad Feldman said the company spent the last year looking for ways to...
Red Orbit  Oct 20  Comment 
April Flowers for redOrbit.com – Your Universe Online The State of Alaska and a group of plaintiffs that include hunters and the California Cattlemen's Association, has appealed a federal court ruling from last year that upheld the 2008...
Benzinga  Oct 4  Comment 
Neuralstem (NYSE: CUR) announced that Eva Feldman, MD, PhD, principal investigator of the Phase I trial to test Neuralstem's human spinal cord stem cells, NSI-566, in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease),...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki